Improved non-redundant species screening panels for benchmarking the performance of new investigational antibacterial candidates against Category A and B priority pathogens

BACKGROUND: NIAID has a programme for testing drug candidates against biodefense and emerging bacterial pathogens that uses defined strain panels consisting of standard laboratory reference strains and strains of clinical origin. OBJECTIVES: The current studies were performed to assess the activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jason E., Abdo, Zaid, Slayden, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947225/
https://www.ncbi.nlm.nih.gov/pubmed/35350133
http://dx.doi.org/10.1093/jacamr/dlac028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947225/
https://www.ncbi.nlm.nih.gov/pubmed/35350133
http://dx.doi.org/10.1093/jacamr/dlac028

Ejemplares similares